APA (7th ed.) Citation

AJ, S., AR, J., BN, R., SA, T., & JS, B. (2019). A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasone. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 25(7), 1692. https://doi.org/10.1177/1078155218815283

Chicago Style (17th ed.) Citation

AJ, Schepers, Jones AR, Reeves BN, Tuchman SA, and Bates JS. "A Comparison of Response in the Presence or Absence of a Delay in Induction Therapy with Bortezomib, Lenalidomide, and Dexamethasone." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 25, no. 7 (2019): 1692. https://doi.org/10.1177/1078155218815283.

MLA (9th ed.) Citation

AJ, Schepers, et al. "A Comparison of Response in the Presence or Absence of a Delay in Induction Therapy with Bortezomib, Lenalidomide, and Dexamethasone." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 25, no. 7, 2019, p. 1692, https://doi.org/10.1177/1078155218815283.